IRIS
CAPODANNO, DAVIDE FRANCESCO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.563
AS - Asia 9.443
EU - Europa 9.183
SA - Sud America 1.780
AF - Africa 733
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 9
Totale 39.727
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.780
SG - Singapore 5.352
RU - Federazione Russa 3.008
CN - Cina 2.807
IE - Irlanda 1.916
UA - Ucraina 1.782
BR - Brasile 1.551
IT - Italia 1.157
CA - Canada 689
VN - Vietnam 569
CI - Costa d'Avorio 537
SE - Svezia 302
GR - Grecia 194
GB - Regno Unito 166
KR - Corea 156
DE - Germania 136
IN - India 123
AR - Argentina 89
FI - Finlandia 70
NL - Olanda 70
FR - Francia 62
MX - Messico 61
SN - Senegal 61
CH - Svizzera 60
AT - Austria 58
BD - Bangladesh 58
PL - Polonia 58
EC - Ecuador 50
UZ - Uzbekistan 49
IQ - Iraq 48
ID - Indonesia 46
TR - Turchia 43
HK - Hong Kong 41
ZA - Sudafrica 41
ES - Italia 35
JP - Giappone 31
BE - Belgio 27
BJ - Benin 23
CO - Colombia 21
MA - Marocco 21
VE - Venezuela 21
PK - Pakistan 18
NG - Nigeria 16
EU - Europa 15
KE - Kenya 15
PE - Perù 14
PY - Paraguay 14
CZ - Repubblica Ceca 13
IR - Iran 12
BG - Bulgaria 10
LB - Libano 10
LT - Lituania 10
AE - Emirati Arabi Uniti 9
UY - Uruguay 9
AZ - Azerbaigian 8
RO - Romania 8
AL - Albania 7
BY - Bielorussia 7
CL - Cile 7
JO - Giordania 7
PH - Filippine 7
EG - Egitto 6
JM - Giamaica 6
MY - Malesia 6
NP - Nepal 6
SA - Arabia Saudita 6
PA - Panama 5
RS - Serbia 5
TN - Tunisia 5
BH - Bahrain 4
CR - Costa Rica 4
HN - Honduras 4
KZ - Kazakistan 4
OM - Oman 4
SI - Slovenia 4
AU - Australia 3
BO - Bolivia 3
GE - Georgia 3
IL - Israele 3
MK - Macedonia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AF - Afghanistan, Repubblica islamica di 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
BZ - Belize 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
QA - Qatar 2
TV - Tuvalu 2
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
Totale 39.707
Salva come PNG Salva come JPEG
Città #
Dallas 3.105
Singapore 2.911
Jacksonville 2.344
Santa Clara 2.024
Dublin 1.913
Chandler 1.363
Moscow 1.024
Boardman 925
Ashburn 673
Nanjing 637
Houston 632
Abidjan 537
Lawrence 535
Andover 530
Cambridge 529
Toronto 502
Chicago 439
Hefei 423
Catania 397
Des Moines 372
Los Angeles 239
Nanchang 227
San Mateo 227
Beijing 205
Civitanova Marche 201
Wilmington 186
Hebei 173
Seoul 156
Shenyang 151
Ho Chi Minh City 142
São Paulo 142
Dong Ket 141
Athens 137
Ottawa 134
Jiaxing 115
Tianjin 113
Saint Petersburg 112
Hanoi 110
Buffalo 108
Changsha 88
Milan 68
New York 64
Dakar 61
Washington 56
Rome 49
Lappeenranta 48
Council Bluffs 47
Seattle 46
Brooklyn 45
Rio de Janeiro 44
Bremen 41
Norwalk 41
Hong Kong 39
Hangzhou 38
Warsaw 38
Redondo Beach 36
Belo Horizonte 35
Jinan 33
Kunming 33
Phoenix 33
Stockholm 31
Atlanta 30
Pune 30
Boston 29
Ningbo 29
San Jose 29
Curitiba 28
Montreal 28
San Francisco 28
Porto Alegre 27
Brussels 26
Amsterdam 25
Chennai 25
Denver 25
Columbus 24
Den Haag 24
Palermo 24
Cotonou 23
Johannesburg 23
Liberty Lake 23
The Dalles 23
Tokyo 23
Zhengzhou 23
Brasília 22
Mexico City 21
Helsinki 20
Guayaquil 19
Orem 19
Da Nang 18
Gravina di Catania 18
Campinas 17
Guarulhos 17
London 17
Abuja 16
Charlotte 16
Edinburgh 16
Guangzhou 16
Haiphong 16
Munich 16
Ribeirão Preto 16
Totale 26.717
Salva come PNG Salva come JPEG
Nome #
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients 535
Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold 245
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds versus Everolimus-Eluting Stents: a Propensity Matched Comparison of the GHOST-EU and XIENCE V USA Registries 197
A Risk Model for Prediction of One-Year Mortality in Patients Undergoing MitraClip Implantation 167
Incorporating glomerular filtration rate or creatinine clearance by the modification of diet in renal disease equation or the Cockcroft-Gault equations to improve the global accuracy of the Age, Creatinine, Ejection Fraction [ACEF] score in patients undergoing percutaneous coronary intervention 154
A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score 147
[Management of severe stenosis controversies and promises] 143
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2 140
Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry. 136
A focused update on emerging prognostic determinants in distal left main percutaneous coronary intervention 134
A novel 3-d reconstruction system for the assessment of bifurcation lesions treated by the mini-crush technique 127
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 125
Optimized Screening of Coronary Artery Disease With Invasive Coronary Angiography and Ad Hoc Percutaneous Coronary Intervention During Transcatheter Aortic Valve Replacement 125
A comparison between Endeavor and Endeavor Resolute drug-eluting stents: outcome at six months follow up 124
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 124
A comparison between Endeavor and Endeavor Resolute drug-eluting coronary stents: outcomes at six month follow up 124
Pharmacological and Clinical Appraisal of Factor XI Inhibitor Drugs. 122
Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography in the Guidance of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis. 122
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement. 122
A post-hoc analysis of the CUSTOMIZE Registry on the differential impact of EuroSCORE and SYNTAX score in Left Main Patients with Intermediate Global Risk 120
Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke : JACC State-of-the-Art Review 119
Incidence of Long-Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement 119
Effect of post-procedural evidence-based therapy on 2-year prognosis after transcatheter mitral valve repair 118
Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients 118
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 118
Platelet function profiles in the elderly: Results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity. 116
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice 116
SYNTAX Score II predicts carotid disease in a multivessel coronary disease population 115
The treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds 114
Acute Left Atrial Spontaneous Echo Contrast and Suspicious Thrombus Formation Following Mitral Regurgitation Reduction With The MitraClip System 114
Assessment of Noninferiority Margins in Cardiovascular Medicine Trials 112
A Multidisciplinary Consensus Document on Follow-up Strategies for Patients Treated with Percutaneous Coronary Intervention 112
Prevalence of renal artery stenosis in patients undergoing cardiac catheterization 110
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes 110
Cigarette Smoking is Associated with a Dose-Response Effect in Clopidogrel Treated Patients with Diabetes Mellitus and Coronary Artery Disease: Results of a Pharmacodynamic Study 108
Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation. 108
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 108
2021 ESC/EACTS Guidelines for the management of valvular heart disease 107
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 105
Recent acquisitions and advances in the knowledge of coronary flow disturbances after percutaneous coronary intervention 104
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 103
Late Self-Apposition With One-Year Persisting Uncoverage of Malapposed Bioresorbable Polymeric Struts 103
Prevention of Acute Kidney Injury with the RenalGuard System in patients undergoing Transcatheter Aortic Valve Implantation: The PROTECT-TAVI trial 103
Temporal patterns of early neointimal strut coverage of the CATANIA stent compared with drug eluting stents and bare metal stent: the Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 100
Long-term clinical and echocardiographic outcomes of Mitraclip therapy in patients nonresponders to cardiac resynchronization 100
A Risk-Scoring Model to Predict One-year Major Adverse Cardiac Events after Percutaneous Coronary Intervention 99
Suitability for elderly with heart disease of a QR code-based feedback of drug intake: Overcoming limitations of current medication adherence telemonitoring systems 98
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 98
Eligibility to Intensified Antithrombotic Regimens for Secondary Prevention in Patients Who Underwent Percutaneous Coronary Intervention 97
Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry 97
Miocardio non compattato del ventricolo sinistro e aneurisma del setto interatriale con difetto. Associazione casuale? 96
Three-Dimensional Angle Assessment and Plaque Distribution Classification in Left Main Disease: Impact of Geometry on Outcome 96
Atrial and ventricular function in thalassemic patients with supraventricular arrhythmias 95
Intraoperative defibrillation threshold testing durino implantable cardioverter-defibrillator insertion: Do we really need it? 95
Predictive Accuracy of CHA2DS2-VASc and HAS-BLED Scores In Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention And Discharged On Dual Antiplatelet Therapy 95
Early discharge in acute myocardial infarction after clinical and angiographic risk assessment 94
Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture 94
Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery 94
Antithrombotic Therapy for Secondary Prevention in Patients with Cerebrovascular Disease 94
Feasibility and Predictors of Early Discharge After Percutaneous Edge-to-Edge Mitral Valve Repair 94
The year in cardiology 2017: coronary interventions 94
Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes 94
Reply: Validity of Randomized Trials Comparing Radial Versus Femoral Access in Acute Coronary Syndrome 93
Association of Tricuspid Regurgitation With Clinical and Echocardiographic Outcomes After Percutaneous Mitral Valve Repair With the MitraClip System: Thirty-Day and Twelve-Month Follow-up From the GRASP Registry 93
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. 93
PCSK9 inhibitors: current status and emerging frontiers in lipid control 92
Antithrombotic Therapy in Patients with Chronic Kidney Disease 92
Bioresorbable vascular scaffold in patients with complex coronary artery disease. 92
The inflammatory abdominal aortic aneurysm and coronary artery disease. Case report and review 92
Clinical implication of different plaque distribution patterns in distal left main coronary artery 92
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score 92
Standardised Definitions of Structural Deterioration and Valve Failure in Assessing Long-Term Durability of Transcatheter and Surgical Aortic Bioprosthetic Valves: A Consensus Statement from The European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 92
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. 92
Characteristics and Impact of Randomized Trials on Drugs or Devices in Cardiovascular Medicine 91
Contrast Transesophageal Echocardiography Using the AcuNav Ultrasound Catheter Through Mouth Way as a Guide to Percutaneous Closure of Patent Foramen Ovale 91
Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds: Implications for Manufacturers and Next Device Iterations 91
Operator volume and mortality in percutaneous coronary intervention: a call for better competency metrics 91
Diabetes mellitus: the scary killer haunting silently 90
Upcoming TAVI trials: rationale, design and likely impact on clinical practice 90
Very Late Outcomes of Drug-Eluting Stents: The "Catch-Down" Phenomenon 90
Impact of Pentoxifylline on Platelet Function Profiles in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel 90
Long-Term Follow-Up after Drug Eluting Stent Implantation in Left Main Trifurcations 89
Mechanisms, Pathophysiology, and Clinical Aspects of Incomplete Stent Apposition 89
Tailoring duration of DAPT with risk scores 89
Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies 89
Pretreatment with Antiplatelet Agents in the Setting of Percutaneous Coronary Intervention: When and Which Drugs? 89
Transcatheter aortic valve implantation in 2017: state of the art 89
Spontaneous coronary artery dissection 88
Management issues of chronic therapy with non-vitamin K oral anticolagulants or antiplatelet agents: different or alike? 88
Local delivery versus intracoronary infusion of abciximab in patients with acute coronary syndromes 88
Effects of Cangrelor in Coronary Artery Disease Patients With and Without Diabetes Mellitus: An In Vitro Pharmacodynamic Investigation 88
Haemostatic Profiles Assessed by Thromboelastography in Patients with End-Stage Renal Disease 87
New-onset coronary aneurism and late-acquired incomplete scaffold apposition after full polymer jacket of a chronic total occlusion with bioresorbable scaffolds 87
Functional profile of the platelet P2Y12 receptor signaling pathway in patients with diabetes mellitus and coronary artery disease 87
Impact of Gastric Acid Suppressing Therapies on Platelet Reactivity in Patients with Coronary Artery Disease treated with Clopidogrel: Results of a Pharmacodynamic Study 87
Mini-crush versus T-provisional techniques in bifurcation lesions: clinical and angiographic long term outcome after implantation of drug–eluting stents 86
Reply: plaque rupture in stable coronary artery disease 86
Current Status and Clinical Development of Transcatheter Approaches for Severe Mitral Regurgitation 86
Progresses in interventional cardiology: focus on patent foramen ovale, coronary intervention, antithrombotic pharmacology, and more 86
Optimal P2Y12 inhibitor for primary PCI in STEMI: Network meta-analysis in the data-fre zone. Do you believe in magic? 86
Totale 11.020
Salva come PNG Salva come JPEG
Categoria #
all - tutte 144.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 144.938
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.645 0 0 0 0 0 112 495 6 264 24 518 226
2021/20223.761 494 579 11 50 618 12 558 99 331 5 83 921
2022/20235.180 545 67 40 349 671 985 9 814 1.432 34 172 62
2023/20242.393 125 494 111 192 100 372 50 104 17 79 472 277
2024/20258.376 96 1.246 605 325 1.999 674 153 360 706 968 450 794
2025/202612.441 1.039 914 3.400 1.186 3.137 2.765 0 0 0 0 0 0
Totale 40.513